PharmD, University of Toronto, Toronto, Ontario, Canada
Dr. Nabil Tadros is Director of our Real-World Evidence (RWE) service offering at PDCI Market Access, a division of McKesson Canada Corporation. Nabil has been a health care Consultant with McKesson for over 23 years, specializing in market access strategy, reimbursement, medical writing, and real-world evidence (RWE) studies. He has an undergraduate degree in Pharmacy from Massachusetts College of Pharmacy and a Doctor of Pharmacy degree from the University of Toronto. Nabil has also worked as a pharmacist in both Canada and the U.S. His clinical education, practical experience as a health care provider, and broad expertise as a Consultant with McKesson for over two decades has given him a unique and keen understanding of the complex therapeutic, market access, and health care issues faced by patients, providers, manufacturers, and payers.
Nabil has helped bring many, significant products to the Canadian market, having worked in over 40 therapeutic areas, including oncology, immunology, hepatology, ophthalmology, and rare diseases. In doing so, Nabil has developed solutions to complex market access problems, provided our customers with rich insights on the Canadian health care environment, and successfully completed numerous public and private payer submissions. In his three decades as a health care professional and consultant, Nabil has consistently helped patients gain access to much needed drug therapy.